2018 Advances in Quantum Computing, Drug Delivery, and Investigational Therapies for Diabetes and Other Disorders - ResearchAndMarkets.com
Wednesday, 09 January 2019 01:06
Jan. 9, 2019 11:32 UTC

2018 Advances in Quantum Computing, Drug Delivery, and Investigational Therapies for Diabetes and Other Disorders - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)-- The "Latest Advances in Quantum Computing, Drug Delivery, and Investigational Therapies for Diabetes and Other Disorders" report has been added to ResearchAndMarkets.com's offering.

The Life Science, Health & Wellness TOE depicts the current landscape and the new life sciences trends across twelve groundbreaking drug discovery and genetic platforms.

Each and every platform is accurately profiled covering the most cutting-edge technologies energizing the pharmaceutical landscape, such as quantum computing in life sciences, innovations in drug delivery, and novel investigational therapies for diabetes and other disorders.

Topics Covered

1. Growth Opportunities in Life Sciences - Health & Wellness

  • Exploring the Potential of Novel Platforms in Life Sciences
  • Diamond Solutions for Nanoscale Imaging
  • Quantum Sequencing Technology
  • Quantum Machine Learning for Gene Regulation
  • High-throughput Quantum Mechanics for Drug Discovery
  • Preclinical Promise of JAK1 Inhibitor Drug for Asthma
  • Clinical Study of a Gene Silencing Drug for Hepatitis B Infection
  • Stem Cell-derived Replacement Therapy for Diabetes
  • 510(k) Clearance for gammaCore for Prevention of Cluster Headaches
  • Nanoparticle Delivery to Improve Osteoarthritis Regenerative Therapies
  • Thymocyte Signaling Mechanism Discovery and Autoimmune Disorders
  • Phase 3 Success of TALICIA for Helicobacter Pylori Infection
  • Real-time Tumor Imaging Agent from Scorpion Venom

2. Industry Relations

  • Regional Practice Leaders and Innovation Experts

For more information about this report visit https://www.researchandmarkets.com/research/khd8lx/2018_advances_in?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Computing, Drug Delivery, Diabetes Devices , Diabetes Drugs


Source: Research and Markets




"Featured Content" profiles are meant to provide awareness of these companies to investors in the small-cap and growth equity community and should not in any way come across as a recommendation to buy, sell or hold these securities. BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter